首页> 美国卫生研究院文献>Global Pediatric Health >Early-Life Pseudomonas aeruginosa Infection in Cystic Fibrosis and Lung Disease Progression
【2h】

Early-Life Pseudomonas aeruginosa Infection in Cystic Fibrosis and Lung Disease Progression

机译:早期生命的铜绿假单胞菌感染在囊性纤维化和肺疾病进展中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lung disease in cystic fibrosis (CF) starts early, with studies identifying abnormalities on chest computed tomography (CT) scan even in infancy. In this retrospective study, abnormal chest CT was the main outcome; body mass index (BMI) z score and forced expiratory volume percent predicted (FEV1%) predicted at age 6 to 7 years were secondary outcomes. Pseudomonas aeruginosa infection prior to 12 months of age was the main explanatory variable. There was no association between early P aeruginosa infection and abnormal CT after adjustment for CFTR (cystic fibrosis transmembrane conductance regulator) functional mutation class, gender, and other pathogens (odds ratio = 0.30; 95% confidence interval = 0.07-1.35; P = .11). No significant associations were demonstrated for BMI z score and FEV1% predicted. Children with class I-III CFTR mutations had increased risk of abnormal CT findings (odds ratio = 11.67; 95% confidence interval = 1.11-115.06; P = .035) and lower FEV1% predicted (P = .04). In the current era, early-life P aeruginosa infection in CF might not influence the severity of lung disease in school age as much as previously. Larger studies are needed to confirm this finding.
机译:囊性纤维化(CF)的肺部疾病较早开始,研究发现即使在婴儿期,胸部CT扫描也能发现异常。在这项回顾性研究中,胸部CT异常是主要结果。次要结果是在6至7岁时预测的体重指数(BMI)z得分和预计的呼气量百分比(FEV1%)。主要的解释变量是12个月大以前的铜绿假单胞菌感染。校正CFTR(囊性纤维化跨膜电导调节剂)功能突变类别,性别和其他病原体后,早期铜绿假单胞菌感染与CT异常之间无关联(优势比= 0.30; 95%置信区间= 0.07-1.35; P =。 11)。 BMI z得分和FEV1%预测值均无显着相关性。患有I-III级CFTR突变的儿童具有更高的CT异常发现风险(几率= 11.67; 95%置信区间= 1.11-115.06; P = .035),而预计的FEV1%较低(P = .04)。在当前时代,CF早期的铜绿假单胞菌感染可能不会像以前那样影响学龄期肺部疾病的严重程度。需要更大的研究来证实这一发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号